Kala BioKALA
13F holders, Q2 2025 (June 30)28holders +1
4new positions
4sold out
1famous investor
$4.76avg. 13F price*
At the end of Q2 2025, 28 institutions reported holding Kala Bio Inc. (KALA) in their 13F filings, up 1 from Q1 2025. 4 opened new positions and 4 sold out. The largest holders were Baker Bros. Advisors LP ($5.7M), Cormorant Asset Management, LP ($2.9M) and SR One Capital Management, LP ($2.9M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Kala Bio Inc.
- CUSIP
- 483119202
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $145K |
| Exits | 4 | $1.7M |
All 13F filers, Q1 2025 → Q2 2025: 195,812 shares bought and 695,798 shares sold, net −499,986 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 28 holders
| Baker Bros. Advisors LP | 0.06% | No change | 1,201,894 | $5.7M |
| Cormorant Asset Management, LP | 0.21% | No change | 603,027 | $2.9M |
| SR One Capital Management, LP | 0.62% | No change | 598,940 | $2.9M |
| Woodline Partners LP | 0.01% | Add +16.0% | 300,149 | $1.4M |
| AIGH Capital Management LLC | 0.67% | Add +52.8% | 300,000 | $1.4M |
| Vanguard Group Inc. | 0.00% | Add +11.5% | 170,375 | $811K |
| ADAR1 Capital Management, LLC | 0.12% | Reduce -49.9% | 149,830 | $713K |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0.02% | Reduce -18.9% | 138,556 | $660K |
| Geode Capital Management, LLC | 0.00% | Add +2.8% | 56,367 | $268K |
| Perceptive Advisors LLC | 0.01% | Reduce -80.1% | 55,227 | $263K |
| BlackRock, Inc. | 0.00% | No change | 21,356 | $102K |
| Renaissance Technologies | 0.00% | New | 17,400 | $83K |
| XTX Topco Ltd | 0.00% | New | 12,990 | $62K |
| Northern Trust Corp. | 0.00% | No change | 10,399 | $49K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +417.2% | 1,143 | $5K |
| Covestor Ltd | 0.00% | Reduce -0.2% | 1,138 | $5K |
| Morgan Stanley | 0.00% | No change | 972 | $5K |
| MAI Capital Management | 0.00% | No change | 300 | $1K |
| JPMorgan Chase & Co. | 0.00% | Add +295.0% | 237 | $1K |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 120 | $571 |
| Osaic Holdings, Inc. | 0.00% | New | 100 | $476 |
| Bank of America Corp. | 0.00% | Add +100.0% | 98 | $466 |
| BNP Paribas Financial Markets | 0.00% | No change | 98 | $466 |
| UBS Group AG | 0.00% | Reduce -99.0% | 34 | $162 |
| Legacy Investment Solutions, LLC | 0.00% | — | 25 | $119 |
| Legacy Wealth Managment, LLC | 0.00% | No change | 25 | $119 |
| SBI Securities Co., Ltd. | 0.00% | No change | 8 | $38 |
| Raymond James Financial Inc. | 0.00% | New | 7 | $33 |
"% of holder's portfolio" is KALA's weight in each manager's 13F, not the share of Kala Bio Inc. the manager owns.